Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Operating Expenses | 3,577 | 2,430 | 2,303 | 1,582 | 2,374 |
| Operating Income | -3,577 | -2,430 | -2,303 | -1,582 | -2,374 |
| Interest Expense | 0 | 2 | 44 | 384 | 209 |
| Other Income | 27 | 34 | 3 | 16 | 33 |
| Pre-tax Income | -3,550 | -2,398 | -2,344 | -1,950 | -2,550 |
| Net Income Continuous | -3,550 | -2,398 | -2,344 | -1,950 | -2,550 |
| Net Income | $-3,550 | $-2,398 | $-2,344 | $-1,950 | $-2,550 |
| EPS Basic Total Ops | -1,500.00 | -1,150.00 | -1,850.00 | -1,500.00 | -1,950.00 |
| EPS Basic Continuous Ops | -1,480.59 | -1,151.46 | -1,418.67 | -1,407.16 | -1,857.17 |
| EPS Diluted Total Ops | -1,500.00 | -1,150.00 | -1,850.00 | -1,500.00 | -1,950.00 |
| EPS Diluted Continuous Ops | -1,480.59 | -1,151.46 | -1,418.67 | -1,407.16 | -1,857.17 |
| EBITDA(a) | $-3,521 | $-2,379 | $-2,253 | $-1,530 | $-2,322 |